Probiotics for Gastrointestinal Disease Conditions
Upon completion of this session, you should be able to:
1. Identify four methods by which the intestinal microflora can be altered.
2. Determine appropriate therapeutic use of probiotics in gastrointestinal diseases, e.g. antibiotic-associated diarrhea, acute diarrhea, IBD, IBS, H pylori.
3. Assess the safety of probiotic therapy.
View technical requirements (opens in a new window).
View CME credit information (opens in a new window).
View disclosures and disclaimers (opens in a new window).
All materials herein are protected by copyright and are for the sole, personal use of the purchaser. No part of the written, oral, and broadcast production may be copied, duplicated, replicated or retransmitted without the prior permission of the applicable copyright owner.
The unauthorized reproduction or distribution of a copyrighted work is illegal. Criminal copyright infringement, including infringement without monetary gain, is investigated by the FBI and is punishable by up to five years in federal prison and a fine of $250,000.
Thad Wilkins, MD, FAAFP, Professor, Director of Academic Development, Department of Family Medicine, Medical College of Georgia, Georgia Regents University, Augusta, Georgia
- 0.75 AAFP prescribed